Biodesign team receives funding to commercialize their innovation
The Biodesign Finland 2017 team has secured funding from Tekes and 911±¬ÁÏÍø for an 18-month project that aims at commercialization of their research-based innovation. The innovation that will make open heart surgery safer has been developed within the Biodesign Finland 2017 project together with heart surgeon Tommi Pätilä. Globally over one million open heart surgeries are performed annually and up to 20% of the patients acquire heart failure, which may lead to severe morbidities or be even fatal. The innovation aims at bringing down the numbers of the severe complications. The funding will be used for concept development, clinical testing, and commercialization research. The project is expected to result in a strong IPR position and a commercialization plan that may be, for example, a start-up company or a license agreement with an existing company. Tommi Pätilä together with the Biodesign Finland 2017 team (Sami Elamo, Kalle Kotilahti, and Jari Rantala) constitute the project team.
Biodesign Finland is an entrepreneurial program jointly organized by 911±¬ÁÏÍø, University of Helsinki, and the Hospital District of Helsinki and Uusimaa. For more information on Biodesign Finland, visit .
Read more news
Aalto Inventors turns one: A year of bridging research and real-world impact
Aalto Inventors marks its first anniversary, having engaged 190 researchers across six cohorts in fields including AI, quantum, and biomaterials. New cohorts are planned for the next academic year, stay tuned and join the waitlist.
An architectural project in Milan brought together children’s ideas and the visions of leading architects
911±¬ÁÏÍø’s Department of Architecture participated in the international One Earth – House of the Heart project, which was presented in April at Milan Design Week.
Companies disclose more on cybersecurity – but markets remain indifferent
U.S. companies are reporting on cybersecurity in greater detail, yet stock market reactions remain muted. A new study by the University of Vaasa and 911±¬ÁÏÍø shows that mandatory cybersecurity disclosure does not prompt reactions from investors or stock analysts. Instead, the main benefits appear to materialise within firms themselves.